# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-087270
Filing Date
2023-11-15
Accepted
2023-11-15 08:00:45
Documents
84
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0923_abvcbio.htm iXBRL | 10-Q | 1504775
2 | LICENSE AGREEMENT BETWEEN THE COMPANY AND AIBTL BIOPHARMA, INC | f10q0923ex10-40_abvcbio.htm | EX-10.40 | 34063
3 | LICENSE AGREEMENT BETWEEN THE BIOLITE AND AIBTL BIOPHARMA, INC | f10q0923ex10-41_abvcbio.htm | EX-10.41 | 33861
4 | CERTIFICATION | f10q0923ex31-1_abvcbio.htm | EX-31.1 | 8146
5 | CERTIFICATION | f10q0923ex31-2_abvcbio.htm | EX-31.2 | 8138
6 | CERTIFICATION | f10q0923ex32-1_abvcbio.htm | EX-32.1 | 5955
7 | CERTIFICATION | f10q0923ex32-2_abvcbio.htm | EX-32.2 | 4021
| Complete submission text file | 0001213900-23-087270.txt |  | 8044718

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | abvc-20230930.xsd | EX-101.SCH | 83616
9 | XBRL CALCULATION FILE | abvc-20230930_cal.xml | EX-101.CAL | 41581
10 | XBRL DEFINITION FILE | abvc-20230930_def.xml | EX-101.DEF | 363574
11 | XBRL LABEL FILE | abvc-20230930_lab.xml | EX-101.LAB | 685749
12 | XBRL PRESENTATION FILE | abvc-20230930_pre.xml | EX-101.PRE | 376922
78 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0923_abvcbio_htm.xml | XML | 1064839

Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 231409083
SIC: 2834 Pharmaceutical Preparations